HRMY Live signaler | Maksimer profitt med Getagraph.com

SELG 107081 min ago

@ $32.54

Utstedt: 13 feb 2024 @ 21:42

Avkastning: -9.88%

Forrige signal: feb 12 - 20:47

Forrige signal: Kjøp

Avkastning: -6.62 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States...

Stats
Dagens volum	368 849
Gjennomsnittsvolum	373 238
Markedsverdi	1.66B
EPS	$0 ( 2024-02-22 )
Neste inntjeningsdato	( $0.640 ) 2024-04-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	13.77
ATR14	$0.0290 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Kapadia Sandip	Buy	15 000	Common Stock
2024-03-29	Kapadia Sandip	Sell	15 000	Restricted Stock Units
2024-03-29	Kapadia Sandip	Sell	8 013	Common Stock
2024-03-15	Dierks Jeffrey	Buy	11 979	Common Stock
2024-03-15	Dierks Jeffrey	Sell	9 644	Stock Option

INSIDER POWER
18.60
Last 99 transactions
Buy: 1 264 876 \| Sell: 2 130 732

Volum Korrelasjon

Lang: -0.14 (neutral)

Kort: 0.27 (neutral)

Signal:(47.646) Neutral

Harmony Biosciences Korrelasjon

10 Mest positive korrelasjoner
NTCT	0.911
VIEW	0.911
RPRX	0.908
ALRS	0.906
RBB	0.896
ORRF	0.885
RPTX	0.881
BMRA	0.879
INCR	0.877
AYTU	0.877

10 Mest negative korrelasjoner
CVT	-0.916
CIFR	-0.904
COUP	-0.896
ACCD	-0.896
CRVL	-0.89
RAM	-0.889
CMPO	-0.889
CLBT	-0.888
DUOL	-0.886
DFH	-0.885

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Harmony Biosciences Korrelasjon - Valuta/Råvare

0.00
( neutral )

-0.04
( neutral )

0.00
( neutral )

0.15
( neutral )

-0.23
( neutral )

Harmony Biosciences Økonomi

Annual	2023
Omsetning:	$582.02M
Bruttogevinst:	$460.79M (79.17 %)
EPS:	$2.17

FY	2023
Omsetning:	$582.02M
Bruttogevinst:	$460.79M (79.17 %)
EPS:	$2.17

FY	2022
Omsetning:	$437.86M
Bruttogevinst:	$354.37M (80.93 %)
EPS:	$3.07

FY	2021
Omsetning:	$305.44M
Bruttogevinst:	$249.92M (81.82 %)
EPS:	$0.697

Financial Reports:

No articles found.

Harmony Biosciences

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Sanntidsoppdatering for Harmony Biosciences [HRMY]

Upcoming Earnings Alert